Exact Mass: 643.2757486
Exact Mass Matches: 643.2757486
Found 119 metabolites which its exact mass value is equals to given mass value 643.2757486,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
S-(PGA1)-glutathione
C30H49N3O10S (643.3138494000001)
S-(PGA1)-glutathione is the gluthathione conjugate of prostaglanding A1. This conjugate is a substrate for MRP2 (31). PGA1 was observed to be able to inhibit. MRP2-mediated transport of DNP-SG quite well. S-(PGA1)-glutathione is the gluthathione conjugate of prostaglanding A1. This conjugate is a substrate for MRP2 (31). PGA1 was observed to be able to inhibit
S-(11-OH-9-deoxy-delta9,12-PGD2)-glutathione
C30H49N3O10S (643.3138494000001)
S-(11-OH-9-deoxy-delta9,12-PGD2)-glutathione is the glutathione conjugate of S-(11-OH-9-deoxy-delta9,12-PGD2) [HMDB] S-(11-OH-9-deoxy-delta9,12-PGD2)-glutathione is the glutathione conjugate of S-(11-OH-9-deoxy-delta9,12-PGD2).
S-(9-deoxy-delta12-PGD2)-glutathione
C30H49N3O10S (643.3138494000001)
S-(9-hydroxy-PGA1)-glutathione is the glutathione conjugate of S-(9-deoxy-delta12-PGD2) [HMDB] S-(9-hydroxy-PGA1)-glutathione is the glutathione conjugate of S-(9-deoxy-delta12-PGD2).
S-(9-hydroxy-PGA2)-glutathione
C30H49N3O10S (643.3138494000001)
S-(9-hydroxy-PGA2)-glutathione is the glutathione conjugate of S-(9-hydroxy-PGA2). Inside L1210 cells, PGA2 was initially conjugated to glutathione and then reduced at the 9-keto position to form 9-OH-PGA2-GSH. The 9-OH-PGA2-GSH was then secreted from the cells and apparently degraded to form the CysGly and Cys derivatives. Intracellular glutathione was decreased markedly by the addition of the PGA2 in L1210 and L929 cells. This result confirms that conjugation of PGA2 to glutathione occurs in both cell types. Formation of the 9-OH-PGA2-GSH and other glutathione-related conjugates was prevented when glutathione was depleted by growth in buthionine sulfoximine. The glutathione-depleted cells were insensitive to the cytotoxicity of the PGA2, suggesting that one of the glutathione-related conjugates may be involved in the cytotoxicity of PGA2. These results end the controversy over the metabolism of PGA2 and suggest mechanisms for its antiviral and antigrowth actions. S-(9-hydroxy-PGA2)-glutathione is the glutathione conjugate of S-(9-hydroxy-PGA2)
10,11-Dihydro-12R-hydroxy-leukotriene C4
C30H49N3O10S (643.3138494000001)
This compound belongs to the family of Leukotrienes. These are eicosanoids containing an hydroxyl group attached to the aliphati chain of an arachidonic acid.
11S,15S-dihydroxy-14R-(S-glutathionyl)-5Z,8Z,12E-eicosatrienoic acid
C30H49N3O10S (643.3138494000001)
11S,15S-dihydroxy-14R-(S-glutathionyl)-5Z,8Z,12E-eicosatrienoic acid is classified as a member of the Oligopeptides. Oligopeptides are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. 11S,15S-dihydroxy-14R-(S-glutathionyl)-5Z,8Z,12E-eicosatrienoic acid is considered to be practically insoluble (in water) and acidic. 11S,15S-dihydroxy-14R-(S-glutathionyl)-5Z,8Z,12E-eicosatrienoic acid is an eicosanoid lipid molecule
Methoxymorpholinyldoxorubicin
C32H37NO13 (643.2264792000001)
Sabarubicin
C32H37NO13 (643.2264792000001)
Satavaptan
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist D045283 - Natriuretic Agents > D065092 - Antidiuretic Hormone Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents
2,6,14-Triacetoxy-1-(3-furylcarbonyloxy)-9-(nicotinoyloxy)dihydro-alpha-agarofuran-4-ol
C32H37NO13 (643.2264792000001)
2,6,14-Triacetoxy-9-(3-furylcarbonyloxy)-1-(nicotinoyloxy)dihydro-alpha-agarofuran-4-ol
C32H37NO13 (643.2264792000001)
1beta,7beta,11-triacetoxy-4alpha-hydroxy-5alpha-nicotinoyl-8beta-furanoyldihydroagarofuran|triptersinine F
C32H37NO13 (643.2264792000001)
(?)-(A-c)-8beta-acetoxy-14alpha-benzoyloxy-N-ethyl-13beta,15alpha-dihydroxy-1alpha,6alpha,16beta,18-tetramethoxy-19-oxo-aconitane
1beta,5alpha,11-triacetoxy-4alpha-hydroxy-7beta-nicotinoyl-8beta-furanoyldihydroagarofuran|triptersinine G
C32H37NO13 (643.2264792000001)
Glu Phe Trp Tyr
Glu Phe Tyr Trp
Glu Trp Phe Tyr
Glu Trp Tyr Phe
Glu Tyr Phe Trp
Glu Tyr Trp Phe
Phe Glu Trp Tyr
Phe Glu Tyr Trp
Phe Trp Glu Tyr
Phe Trp Tyr Glu
Phe Tyr Glu Trp
Phe Tyr Trp Glu
Ile Trp Tyr Tyr
Ile Tyr Trp Tyr
Ile Tyr Tyr Trp
Leu Trp Tyr Tyr
Leu Tyr Trp Tyr
Leu Tyr Tyr Trp
Pro Arg Trp Trp
Pro Trp Arg Trp
Pro Trp Trp Arg
Arg Pro Trp Trp
Arg Trp Pro Trp
Arg Trp Trp Pro
Trp Glu Phe Tyr
Trp Glu Tyr Phe
Trp Phe Glu Tyr
Trp Phe Tyr Glu
Trp Ile Tyr Tyr
Trp Leu Tyr Tyr
Trp Pro Arg Trp
Trp Pro Trp Arg
Trp Arg Pro Trp
Trp Arg Trp Pro
Trp Trp Pro Arg
Trp Trp Arg Pro
Trp Tyr Glu Phe
Trp Tyr Phe Glu
Trp Tyr Ile Tyr
Trp Tyr Leu Tyr
Trp Tyr Tyr Ile
Trp Tyr Tyr Leu
Tyr Glu Phe Trp
Tyr Glu Trp Phe
Tyr Phe Glu Trp
Tyr Phe Trp Glu
Tyr Ile Trp Tyr
Tyr Ile Tyr Trp
Tyr Leu Trp Tyr
Tyr Leu Tyr Trp
Tyr Trp Glu Phe
Tyr Trp Phe Glu
Tyr Trp Ile Tyr
Tyr Trp Leu Tyr
Tyr Trp Tyr Ile
Tyr Trp Tyr Leu
Tyr Tyr Ile Trp
Tyr Tyr Leu Trp
Tyr Tyr Trp Ile
Tyr Tyr Trp Leu
14,15-HxA3-C(11S)
C30H49N3O10S (643.3138494000001)
Nemorubicin
C32H37NO13 (643.2264792000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
5-[3-[[3-(Fluorosulfonyl)phenyl]amino]-1,3-dioxopropyl]-2-(hexadecyloxy)benzenesulfonyl fluoride
C31H43F2NO7S2 (643.2448872000001)
Sabarubicin
C32H37NO13 (643.2264792000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
1-[1-Carboxylato-3-[[3-carboxylato-5-[3-[decanoyl(hydroxy)amino]propylamino]-3-hydroxy-5-oxopentanoyl]amino]propyl]-2-hydroxy-5-oxopyrrolidine-2-carboxylate
C28H43N4O13-3 (643.2826488000001)
11S,15S-Dihydroxy-14R-(S-glutathionyl)-5Z,8Z,12E-eicosatrienoate
C30H49N3O10S (643.3138494000001)
10,11-Dihydro-12R-hydroxy-leukotriene C4
C30H49N3O10S (643.3138494000001)
N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-thiophenesulfonamide
C33H45N3O6S2 (643.2749630000001)
N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methoxybenzenesulfonamide
C36H41N3O6S (643.2715926000001)
N-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide
(2R,3R,4S,5R)-2-acetamido-4-[(2S,3R,4R,5S,6R)-3-acetamido-5-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5,6-trihydroxyhexanoic acid
C24H41N3O17 (643.2435856000001)
Satavaptan
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist D045283 - Natriuretic Agents > D065092 - Antidiuretic Hormone Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents
S-(11-OH-9-deoxy-delta9,12-PGD2)-glutathione
C30H49N3O10S (643.3138494000001)
11(S),15(S)-dihydroxy-14(R)-(S-glutathionyl)-5(Z),8(Z),12(E)-icosatrienoic acid
C30H49N3O10S (643.3138494000001)
A glutathione conjugate in which the thiol hydrogen of glutathione has been replaced by a (6S,7R,8E,10S,12Z,15Z)-19-carboxy-6,10-dihydroxynonadeca-8,12,15-trien-7-yl group.
BIBO3304 (TFA)
BIBO3304 TFA is a potent, orally active, and selective neuropeptide Y (NPY) Y1 receptor antagonist, with subnanomolar affinity for both the human and the rat Y1 receptor (IC50=0.38 and 0.72 nM, respectively)[1].
1α-nicotinoyloxy-2α-acetoxy-6β-acetoxy-9β-furoyloxy-11-acetoxy-4β-hydroxydihydro-β-agarofuran
C32H37NO13 (643.2264792000001)
{"Ingredient_id": "HBIN002314","Ingredient_name": "1\u03b1-nicotinoyloxy-2\u03b1-acetoxy-6\u03b2-acetoxy-9\u03b2-furoyloxy-11-acetoxy-4\u03b2-hydroxydihydro-\u03b2-agarofuran","Alias": "NA","Ingredient_formula": "C32H37NO13","Ingredient_Smile": "CC(=O)OCC12C(CC3C(C1(C(CC(C2OC(=O)C4=CN=CC=C4)OC(=O)C)(C)O)OC3(C)C)OC(=O)C)OC(=O)C5=COC=C5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15526","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2s,5s,8s,11s,14r,15r)-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-5-isopropyl-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione
(1s,2s,4s,5r,6r,7s,9r,12r)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate
C32H37NO13 (643.2264792000001)
(2s,5s,11s,14r,15r)-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-5-isopropyl-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione
(1r,2s,4s,5s,6s,7s,9s,12s)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate
C32H37NO13 (643.2264792000001)
4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate
C32H37NO13 (643.2264792000001)